Product Reports Resources Pricing Login Book a demo

Mandolin

Health · San Francisco, United States · Founded 2024

AI workers from Mandolin integrate seamlessly into existing EHR systems, optimizing infusion center operations MoreLess

Mandolin operates as a healthcare technology firm focused on the specialty pharmaceutical market, providing an AI-driven automation platform to streamline administrative processes for accessing life-saving drugs. The company was established in 2024 by CEO Will Yin and COO Rohit Rustagi, repeat entrepreneurs who dropped out of Stanford. Their direction for the company was influenced by personal experiences with family members who struggled with delays in accessing specialty treatments for conditions like cancer and Alzheimer's.

The business targets the significant administrative bottlenecks in the healthcare system, particularly within infusion centers, specialty pharmacies, and health systems. Clients include large providers like Vivo Infusion, FlexCare Infusion, TwelveStone Health Partners, and Amber Specialty Pharmacy, with the platform deployed in over 700 clinic locations, serving more than 250,000 new patients annually. Mandolin's business model is centered on providing its AI platform to automate the end-to-end administrative tasks associated with infused and injected drugs, from patient referral to reimbursement.

Mandolin's core offering is a platform of AI agents that function as a digital workforce. These agents integrate directly into existing Electronic Health Records (EHRs), payer portals, and manufacturer hubs. The technology is designed to handle a variety of complex back-office tasks, such as performing benefits verification, navigating insurance portals, submitting prior authorizations, parsing faxes and clinical notes, and managing billing and claims. By automating these traditionally manual and time-consuming workflows, Mandolin aims to reduce treatment delays from weeks to days, lower operational costs for providers, and improve revenue cycle management. The company has secured significant financial backing, raising $40 million in a funding round from investors including Greylock Partners, SignalFire, Maverick, and SV Angel.

Keywords: specialty drug access, healthcare automation, AI agents, patient access platform, infusion center software, prior authorization automation, revenue cycle management, benefits verification, healthcare AI, specialty pharmacy solutions, EHR integration, clinical workflow automation, drug reimbursement, health tech, back-office automation, patient intake management, medical billing AI, care coordination, specialty therapies, pharmaceutical services

Talent graph

Mandolin's talent

Book a demo to see the people
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on Mandolin's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 6 investors entered at this stage

Global footprint

Where Mandolin has talent and traffic

Workforce by country
🇺🇸 United States · San Francisco HQ
Book a demo for the full country breakdown

Market sentiment

What the market is saying about Mandolin

An AI-synthesized read of the highest-engagement posts about Mandolin on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mandolin on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.